White label – Pompe disease - ClinicalTrials.eu

Long-Term Study for Cancer Patients Using Atezolizumab Therapy

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Atezolizumab
Study Comparing Standard Chemotherapy with CPX-351 for Adults with Newly Diagnosed Acute Myeloid Leukemia (AML) and Intermediate or Adverse Genetics

Not recruiting

3 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
- Daunorubicin
- Cytarabine
Study on Long-Term Safety of Soticlestat for Patients with Dravet or Lennox-Gastaut Syndromes

Not recruiting

3 1 1
Investigated Drugs:
- Soticlestat
+4
Study on Long-Term Effects of Buprenorphine in Adults with Opioid Use Disorder

Not recruiting

3 1 1 1
Investigated Drugs:
- Buprenorphine
Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

Not recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
- Capivasertib
- Fulvestrant
+1
Study Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases

Not recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
- Crizotinib
- Entrectinib
+4
Study on the Effectiveness of Durvalumab and Bevacizumab with TACE in Patients with Localized Liver Cancer

Not recruiting

3 1 1
Investigated Diseases:
- Hepatocellular carcinoma
Investigated Drugs:
Study of Rilzabrutinib for Adults with Relapsed Immune Thrombocytopenia

Not recruiting

1 1 1
Investigated Drugs:
- Rilzabrutinib
Study on the Effects of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Patients with Knee Osteoarthritis

Not recruiting

1 1 1
Investigated Diseases:
- Osteoarthritis
Investigated Drugs:
- Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Expanded
- Sodium Chloride
Study on the Effects of RGX-314 Gene Therapy Compared to Aflibercept and Ranibizumab for Patients with Neovascular Age-Related Macular Degeneration

Not recruiting

3 1 1 1
Investigated Diseases:
- Neovascular age-related macular degeneration
Investigated Drugs:
- Ranibizumab
- Aflibercept

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies